On February 11, 2026, Indaptus Therapeutics, Inc. reduced the exercise prices of warrants for 913,638 shares from $8.30-$47.60 to $1.75, as part of agreements with holders; this reduction helps facilitate a special shareholder meeting on February 26, 2026.